What is Thalidomide?
Category: Prescription Drugs
Most popular types: Thalomid
See also: Bortezomib-thalidomide Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide (VTD-PACE) Bortezomib-thalidomide-dexamethasone (VTd) Dexamethasone-thalidomide-cisplatin-doxorubicin-cyclophosphamide-etoposide (DT-PACE) Melphalan-prednisone-thalidomide (MPT) RT protocol Thalidomide-dexamethasone (Td) Thalidomide-prednisone
Thalidomide is an immunosuppressant agent that may be used for the treatment of multiple myeloma. It is often used in combination with other agents, but it may also be used alone as a maintenance or salvage treatment.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple myeloma | 63 | 1 | |
| Subacute cutaneous lupus erythematosus | 7 | 0 | |
| Behcet's disease | 5 | 0 | |
| Prurigo nodularis | 2 | 2 | |
| Discoid lupus erythematosus | 1 | 1 | |
| Inability to experience pleasure (anhedonia) | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 0 | |
| Mild | 3 | |
| None | 1 |
Commonly reported side effects and conditions associated with Thalidomide
| Side effect | Patients | Percentage |
|---|---|---|
| Depressed mood | 1 | |
| Excessive daytime sleepiness (somnolence) | 1 | |
| Nephronophthisis | 1 |
Why patients stopped taking Thalidomide
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 2 | |
| Did not seem to work | 1 | |
| Doctor's advice | 1 | |
| Side effects too severe | 1 |
Duration
Stopped taking Thalidomide
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 1 | |
| 6 months - 1 year | 2 | |
| 10 years or more | 1 |
What people switch to and from
Patients started taking Thalidomide after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Hydrocortisone topical (Cortizone-10) | 1 | |
| Hydroxyurea (Hydrea) | 1 |
Patients stopped taking Thalidomide and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Lenalidomide (Revlimid) | 2 | |
| Ruxolitinib (Jakafi) | 1 |